215
Views
84
CrossRef citations to date
0
Altmetric
Research Article

Review and Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry

, , , , , , & show all
Pages 329-389 | Published online: 29 Sep 2008

References

  • ICRP, Report of the Task Group on Reference Man. International Com- mission on Radiological Protection, New York, 1972.
  • Mayersohn, M., Pharmacokinetics in the elderly. Environmental Health Perspectives, 102(Suppl 11), 119– 124, 1994.
  • Braunlich, H., Kidney Development: Drug Elimination Mechanisms, in Drug Disposition During Develop- ment, Morselli, P., Ed. Spectrum Pub- lications Inc., New York, 89–101, 1977.
  • Ogiu, N., et al., A statistical analysis of the internal organ weights of nor- mal Japanese people. Health Phys, 72(3),368–83., 1997.
  • Crystal, R.G., et al., Eds., The Lung: Scientific Foundations. Vol. 2. Raven Press: New York, 1991.
  • Plunkett, L.M., Turnbull, D., and Rodricks, J.V., Differences Between Adults and Children Affecting Expo- sure Assessment, in Similarities and Differences Between Children and Adults: Implications for Risk Assess- ment, Guzelian, P., Henry, C., and Olin, S., Eds., ILSI Press, Washing- ton, DC, 79–94, 1992.
  • Bender, A.D., Effect of age on intes- tinal absorption: implications for drug absorption in the elderly. Journal of the American Geriatric Society, 16(12),1331–1339, 1968.
  • Eddington, N.D., Pharmacokinetics, in Handbook of Pharmacology and Aging, Roberts, J., Snyder, D.L., and Friedman, E., Eds., CRC Press, Boca Raton, 1–22, 1996.
  • Klaassen, C.D., Distribution, Excre- tion, and Absorption of Toxicants, in Toxicology: The Basic Science of Poisons, Klaassen, C.D., Amdur, M.O., and Doull, J., Eds., Macmillan Publishing, New York, 33–63, 1980.
  • Beierle, I., Meibohm, B., and Derendorf, H., Gender differences in pharmacokinetics and pharmaco- dynamics. International Journal of Clinical Pharmacology and Thera- peutics, 37(11),529–47, 1999.
  • Bearer, C.F., How are children dif- ferent from adults? Environmental Health Perspectives, 103(Suppl 6), 7–12, 1995.
  • Cunico, R.L., et al., Skin barrier properties in the newborn. Biol Neo- nate, 32(177–182, 1977.
  • Milsap, R.L. and Jusko, W.J., Phar- macokinetics in the infant. Environ- mental Health Perspectives, 102(Suppl 11), 107–110, 1994.
  • Roskos, K.V., Maibach, H.I., and Guy, R.H., The effect of aging on percutane- ous absorption in man. Journal of Phar- macokinetics and Biopharmaceutics, 17(6),617–630, 1989.
  • Reid, L.M., The pulmonary circula- tion: remodeling in growth and dis- ease. The 1978 J. Burns Amberson lecture. Am Rev Respir Dis, 119(4),531–46, 1979.
  • Dunnill, M.S., The problem of lung growth [editorial]. Thorax, 37(8),561–3, 1982.
  • Musante, C.J. and Martonen, T.B., Computer simulations of particle deposi- tion in the developing human lung. Jour- nal of the Air and Waste Management Association, 50(8),1426–1432, 2000.
  • Snodgrass, W., Physiological and Biochemical Differences Between Children and Adults as Determinants of Toxic Response to Environmental Pollutants., in Similarities and Dif- ferences Between Children and Adults: Implications for Risk Assess- ment, Guzelian, P., Henry, C., and Olin, S., Eds., ILSI Press, Washing- ton, DC, 35–42, 1992.
  • Gillooly, M. and Lamb, D., Airspace size in lungs of lifelong non-smok- ers: effect of age and sex. Thorax, 48(1),39–43, 1993.
  • Mauderly, J.L., Effect of age on pul- monary structure and function of im- mature and adult animals and man. Fed Proc, 38(2),173–7., 1979.
  • Cook, D.R., Paediatric anaesthesia: Pharmacological considerations. Drugs, 12(3),212–221, 1976.
  • Roth, W.L., Freeman, R.A., and Wilson, A.G., A physiologically based model for gastrointestinal ab- sorption and excretion of chemicals carried by lipids. Risk Analysis, 13(5),531–543, 1993.
  • Vost, A. and Maclean, N., Hydro- carbon transport in chylomicrons and high-density lipoproteins in rat. Lip- ids, 19(6),423–435, 1984.
  • Stewart, C.F. and Hampton, E.M., Effect of maturation on drug disposi- tion in pediatric patients. Clinical Pharmacology, 6(7),548–564, 1987.
  • Hattis, D., et al., Development of a Comparative Child/Adult Pharmaco- kinetic Database Based Upon the Therapeutic Drug Literature. Clark University and the Connecticut De- partment of Public Health, 2000.
  • Morselli, P.L., Franco-Morselli, R., and Bossi, L., Clinical pharmacoki- netics in newborns and infants. Age- related differences and therapeutic im- plications. Clinical Pharmacokinetics, 5(6),485–527, 1980.
  • Burin, G.J. and Saunders, D.R., Addressing human variability in risk assessment—the robustness of the in- traspecies uncertainty factor. Regu- latory Toxicology and Pharmacol- ogy, 30(3),209–216, 1999.
  • Parkinson, A., Biotransformation of Xenobiotics, in Casarett and Doull’s Toxicology, The Basic Science of Poi- sons, Klaasen, C., Ed. McGraw-Hill, New York, 113 - 186, 1996.
  • Maurel, P., The CYP3 family, in Cy- tochromes P450 Metabolic and Toxi- cological Aspects, C, I., Ed. CRC Press, Boca Raton, FL, 241–270, 1996.
  • de Wildt, S.N., et al., Cytochrome P450 3A: ontogeny and drug disposi- tion. Clinical Pharmacokinetics, 37(6),485–505, 1999.
  • Guengerich, F.P. and Shimada, T., Oxidation of Toxic and Carcinogenic Chemicals by Human Cytochrome P- 450 Enzymes. Chemical Research in Toxicology, 4(4),391–407, 1991.
  • Glue, P. and Clement, R.P., Cyto- chrome P450 enzymes and drug me- tabolism—basic concepts and meth- ods of assessment. Cellular and Molecular Neurobiology, 19 (3),309– 323, 1999.
  • Kovarik, J.M. and Koelle, E.U., Cyclosporin pharmacokinetics in the elderly. Drugs and Aging, 15(3), 197– 205, 1999.
  • Calabrese, E., Xenobiotic Metabo- lism, in Age and Susceptibility to Toxic Substances, Calabrese, E., Ed. John Wiley, New York, 33–78, 1986.
  • Kawajiri, K., Hayashi, S.I., The CYP1 family, in Cytochromes P450 Metabolic and Toxicological Aspects, C, I., Ed. CRC Press, Boca Raton, FL, 77–97, 1996.
  • Shimada, T., et al., Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxi- dation of drugs, carcinogens and toxic chemicals: studies with liver mi- crosomes of 30 Japanese and 30 Cau- casians. Journal of Pharmacology and Experimental Therapeutics, 270(1),414–423, 1994.
  • Tanaka, E., Gender-related differ- ences in pharmacokinetics and their clinical significance. Journal of Clini- cal Pharmacology and Therapeutics, 24(5),339–346, 1999.
  • Sonawane, B.R. and Yaffe, S.J., Clinical implications of hepatic im- maturity: bilirubin glucuronidation and induction by phenobarbital, in Drug Metabolism in the Immature Human, Soyka, L.F., Redmond, G.P., Ed. Raven Press, New York, 119– 128, 1981.
  • Pacifici, G.M., et al., Tissue and spe- cies differences in enzymes of ep- oxide metabolism. Xenobiotica, 11(2),73–79, 1981.
  • Mendrala, A.L., et al., In vitro ki- netics of styrene and styrene oxide metabolism in rat, mouse, and hu- man. Archives of Toxicology, 67(1),18–27, 1993.
  • Rane, A., Pacifici, G.M., Formation and metabolism of toxic metabolites in the human fetus, in Drug Metabo- lism in the Immature Human, Soyka, L.F., Redmond, G.P., Ed. Raven Press, New York, 29–35, 1981.
  • Kauffman, R.E., Acute Acetami- nophen Overdose: An Example of Reduced Toxicity Related to Devel- opmental Differences in Drug Me- tabolism, in Similarities and Differ- ences Between Children and Adults: Implications for Risk Assessment, Guzelian, P., Henry, C., and Olin, S., Eds., ILSI Press, Washington, DC, 97–103, 1992.
  • Klaassen, C.D. and Rozman, K., Ab- sorption, distribution, and excretion of toxicants, in Casarett and Doull’s Toxicology. The Basic Science of Poisons, Amdur, M.O., Doull, J., and Klaassen, C.D., Eds., Pergamon Press, New York, 50–87, 1991.
  • Rozman, K.K. and Klaassen, C.D., Absorption, distribution, and excreiton of toxicants, in Casarett and Doull’s Toxicology. The Basic Science of Poisons, Klaassen, C.D., Amdur, M.O., and Doull, J., Eds., McGraw-Hill, New York, 91–112, 1996.
  • Fullmer, C.S., Intestinal interactions of lead and calcium. NeuroToxicology, 13(4),799–807, 1992.
  • Ritschel, W.A., Ed. Gerontokinetics. Pharmacokinetics of Drugs in the Eld- erly. The Telford Press, Inc.: Caldwell, NJ, 1988.
  • Calabrese, E., Gastrointestinal/ Dermal/Pulmonary Absorption or Xenobiotics: Effect of Age., in Age and Susceptibility to Toxic Sub- stances, Calabrese, E., Ed. John Wiley, New York, 5–24, 1986.
  • Widdicombe, J., Drug uptake from the airways and lungs. Indian Jour- nal of Physiology and Pharmacol- ogy, 42(1),3–14, 1998.
  • Johanson, G., Modeling of Respira- tory Exchange of Polar Solvents. Annals of Occupational Hygiene, 35(3),323–339, 1991.
  • Andersen, M.E., Saturable metabo- lism and its relation to toxicity. Criti- cal Reviews in Toxicology, 9(105–150, 1981.
  • Andersen, M.E., A physiologically based toxicokinetic description of the metabolism of inhaled gases and va- pors: analysis at steady state. Toxicol- ogy and Applied Pharmacology, 60(509–526, 1981.
  • Guilmette, R., Wicks, J., and Wolff, R., Morphometry of human nasal air- ways in vivo using magnetic reso- nance imaging. J Aerosol Med, 2(365– 377, 1989.
  • Sarangapani, R. and Wexler, A.S., Modeling particle deposition in extrathoracic airways. Aerosol. Sci. Technol., 32(72–89), 2000.
  • Schoenberg, J.B., Beck, G.J., and Bouhuys, A., Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol, 33(3),367–93, 1978.
  • Quanjer, P.H., et al., Compilation of reference values for lung function measurements in children. Eur Respir J Suppl, 4(184S-261S., 1989.
  • Sherrill, D.L., Camilli, A., and Lebowitz, M.D., On the temporal re- lationships between lung function and somatic growth. Am Rev Respir Dis, 140(3),638–44, 1989.
  • Hislop, A.A., et al., Postnatal growth and function of the pre-acinar airways. Thorax, 27(265–274, 1972.
  • Krumpe, P.E., et al., The aging res- piratory system. Clin Geriatr Med, 1(1),143–75, 1985.
  • Weibel, E.R., Morphometry of the Human Lung. Berlin, Springer, 151, 1963.
  • Thurlbeck, W.M., Postnatal human lung growth. Thorax, 37(8),564–71, 1982.
  • Crapo, R.O., Pulmonary-function testing. N Engl J Med, 331 (1),25– 30., 1994.
  • Gibson, G.J., et al., Sex and age dif- ferences in pulmonary mechanics in normal nonsmoking subjects. J Appl Physiol, 41(1),20–5., 1976.
  • Leith, D.E. and Mead, J., Mecha- nisms determining residual volume of the lungs in normal subjects. J Appl Physiol, 23(2),221–7., 1967.
  • Mellemgaard, K., The alveolar-arte- rial oxygen difference: its size and components in normal man. Acta Physiol Scand, 67(1),10–20., 1966.
  • Hamer, N., Effect of membrane per- meability on pulmonary as exchange efficiency. Clin. Sci., 23(85, 1962.
  • Krumholz, R.A., Pulmonary mem- brane diffusing capacity and pulmo- nary capillary blood volume: an ap- praisal of their clinical usefulness. Am Rev Respir Dis, 94(2),195–200., 1966.
  • Verbeken, E.K., et al., Anatomy of membranous bronchioles in normal, senile and emphysematous human lungs. J Appl Physiol, 77 (4),1875– 84, 1994.
  • Edge, J., Millard, F., and Reid, L., The radiographic appearance of the chest in persons of advanced age. Br. J. Radiol, 37(769–774, 1984.
  • Petrini, M.F., Phillips, M.S., and Walsh, D.A., Pulmonary tissue vol- ume and blood flow as functions of body surface area and age. Lung, 166(1),47–63., 1988.
  • Hofmann, W., Mathematical model for the postnatal growth of the human lung. Respir Physiol, 49(1),115–29., 1982.
  • Overton, J.H. and Graham, R.C., Predictions of ozone absorption in human lungs from newborn to adult. Health Phys, 57 Suppl 1(4),29–36., 1989.
  • Martonen, T.B., Graham, R.C., and Hofmann, W., Human subject age and activity level: factors addressed in a biomathematical deposition pro- gram for extrapolation modeling. Health Phys, 57 Suppl 1(8),49–59., 1989.
  • Agnew, J.E., Bronchiolar aerosol deposition and clearance. Eur Respir J, 9(6),1118–22., 1996.
  • Stanley, P.J., et al., Effect of betamethasone and betamethasone with neomycin nasal drops on human nasal mucociliary clearance and cili- ary beat frequency. Thorax, 40(8),607–12., 1985.
  • Leikauf, G.D., et al., Dose-depen- dent effects of submicrometer sulfu- ric acid aerosol on particle clearance from ciliated human lung airways. Am Ind Hyg Assoc J, 45(5),285–92., 1984.
  • Davis, J. and Grant, L., The Sensi- tivity of Children to Lead, in Simi-larities and Differences Between Chil- dren and Adults: Implications for Risk Assessment, Guzelian, P., Henry, C., and Olin, S., Eds., ILSI Press, Wash- ington, DC, 150–162, 1992.
  • Swift, D.L., Age-related scaling for aerosol and vapor deposition in the upper airways of humans. Health Phys, 57 Suppl 1(293–7., 1989.
  • Oldham, M.J., Mannix, R.C., and Phalen, R.F., Deposition of mono- disperse particles in hollow models representing adult and child-size tra- cheobronchial airways. Health Phys, 72(6),827–34., 1997.
  • EPA, Air Quality Criteria Document for Particulate Matter, 1996.
  • Bennett, W.D., Zeman, K.L., and Kim, C., Variability of fine particle deposition in healthy adults: effect of age and gender. Am J Respir Crit Care Med, 153(5),1641–7., 1996.
  • Xu, G.B. and Yu, C.P., Effects of age on deposition of inhaled aerosols in the human lung. Aero Sci Tech, 5(359–357, 1986.
  • Phalen, R.F., et al., Tracheobronchial deposition predictions for infants, children and adolescents. Ann Occup Hyg, 32(Suppl), 11–21, 1988.
  • McCue, J.D., Antibiotic use in the elderly: issues and nonissues. Clini- cal Infectious Diseases, 28 (4),750– 752, 1999.
  • Corley, R.A., Gordon, S.M., and Wallace, L.A., Physiologically based pharmacokinetic modeling of the tem- perature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicological Sciences, 53(1),13–23, 2000.
  • Nomiyama, K. and Nomiyama, H., Metabolism of Trichloroethylene in Hu- man. Sex Difference in Urinary Excre- tion of Trichloroacetic Acid and Trichloroethanol. Internationales Archiv Fur Arbeitsmedizin, 28(1),37–48, 1971.
  • Pritchard, J.N., Jefferies, S.J., and Black, A., Sex differences in the re- gional deposition of inhaled particles in the 2.5–7.5 um size range. J Aero Sco, 17(385–389, 1986.
  • Kim, C.S. and Hu, S.C., Regional deposition of inhaled particles in hu- man lungs: comparison between men and women. J Appl Physiol, 84(6),1834–44., 1998.
  • Jaques, P.A. and Kim, C.S., Mea- surement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol, 12(8),715–31., 2000.
  • Crom, W.R., Pharmacokinetics in the child. Environmental Health Perspec- tives, 102(Suppl 11), 111–117, 1994.
  • Ulijaszek, S.J., Johnston, F.E., and Preece, M.A., Eds., Human Growth and Development. Cambridge Uni- versity Press: New York. 497, 1998.
  • DeVane, C.L., Metabolism and phar- macokinetics of selective serotonin reuptake inhibitors. Cellular and Mo- lecular Neurobiology, 19(4),443–466, 1999.
  • Masseyeff, R., et al., Evolution of al- pha-fetoprotein serum levels through- out life in humans and rats, and during pregnancy in the rat. Annals of the New York Academy of Sciences, 259(17–28, 1975.
  • Dunn, J., Transport of Estrogens in Human Plasma, in Catechol Estro- gens, Merriam, G. and Lipsett, M., Eds., Raven Press, New York, 167– 176, 1983.
  • Dunn, J., Computer Simulation of Steroid Transport in Human Plasma, in Computers in Endocrinology, Rodbard, D. and Forti, G., Eds., Raven Press, New York, 277–285, 1984.
  • Zubenko, G.S. and Sunderland, T., Geriatric psychopharmacology: why does age matter? Harvard Review of Psychiatry, 7(6),311–333, 2000.
  • Schussler, G.C., The thyroxine-bind- ing proteins [published erratum ap- pears in Thyroid 2000 Apr;10(4):372]. Thyroid, 10(2),141–149, 2000.
  • Newcomer, M.E., Retinoid-binding proteins: structural determinants im- portant for function. FASEB Journal, 9(2),229–239, 1995.
  • Kurz, H., Mauser-Ganshorn, A., and Stickel, H.H., Differences in the binding of drugs to plasma proteins from newborn and adult man. I. Eu- ropean Journal of Clinical Pharma- cology, 11(6),463–467, 1977.
  • Grandison, M.K. and Boudinot, F.D., Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet, 38(3),271–90, 2000.
  • Hay, W.W., Jr., et al., Eds., Current Pediatric Diagnosis and Treatment, 14th ed. Appleton & Lange: Stam- ford, CT, 1998.
  • Morselli, P.L., Ed. Drug Disposition During Development. Spectrum Pub- lications, Inc.: New York, 1979.
  • Belgorosky, A. and Rivarola, M.A., Progressive decrease in serum sex hor- mone-binding globulin from infance to late prepuberty in boys. J Clin Endocrinol Metab, 63(2),510–512, 1986.
  • Bedecarras, P., et al., Characteriza- tion of serum SHBG isoforms in pre- pubertal and pubertal girls. Clin Endocrinol, 49(5),603–608, 1998.
  • Hakkinen, K. and Pakarinen, A., Serium hormones and strength devel- opment during strength training in middle-aged and elderly males and females. Acta Physiol Scand, 150(2),211–219, 1994.
  • Kurz, H., Michels, H., and Stickel, H.H., Differences in the binding of drugs to plasma proteins from new- born and adult man. II. European Journal of Clinical Pharmacology, 11(6),469–472, 1977.
  • Ritschel, W., et al., Pharmacokinet- ics of coumarin and its 7–hydroxy- metabolites upon intravenous and peroral administration of coumarin in man. European Journal of Clinical Pharmacology, 12(6),457–461, 1977.
  • Gilmore, D.A., et al., Age and gen- der influence the stereoselective phar- macokinetics of propranolol. Journal of Pharmacology and Experimental Therapeutics, 261(3),1181–6, 1992.
  • Cogliano, J., Trichloroethylene health risk assessment: Using mechanistic information to improve dose-response assessment. The Toxicologist, 48(1– S), Abstr # 387, 1999.
  • Veering, B.T., et al., The effect of age on serum concentrations of albu- min and alpha 1–acid glycoprotein. British Journal of Clinical Pharma- cology, 29(2),201–206, 1990.
  • Piafsky, K.M., et al., Increased plasma protein binding of propranolol and chlorpromazine mediated by dis- ease-induced elevations of plasma alpha1 acid glycoprotein. New En-gland Journal of Medicine, 299(26),1435–1439, 1978.
  • Triggs, E. and Charles, B., Pharma- cokinetics and therapeutic drug moni- toring of gentamicin in the elderly. Clinical Pharmacokinetics, 37(4),331–341, 1999.
  • Wilson, K., Sex-related differences in drug disposition in man. Clin Pharmacokinet, 9(3),189–202, 1984.
  • Klinger, W., Development of Drug Metabolizing Enzymes, in Drug Dis- position During Development, PL, M., Ed. Spectrum Publications, Inc., New York, 71–87, 1977.
  • Birkett, D.J. and Grygiel, J.J., Age determinants of methylxanthine me- tabolism in man, in Drug Metabolism in the Immature Human, Soyka LF, R.G., Ed. Raven Press, New York, 229–239, 1981.
  • Cresteil, T., Onset of xenobiotic me- tabolism in children: toxicological im- plications. Food Additives and Con- taminants, 15(Suppl), 45–51, 1998.
  • Lacroix, D., et al., Expression of CYP3A in the human liver—evidence that the shift between CYP3A7 and CYP3A4 occursimmediately after birth. Eur J Biochem, 247(2)(625– 634, 1997.
  • Jacqz-Aigrain, E. and Cresteil, T., Cytochrome P450–dependent me- tabolism of dextromethorphan: fetal and adult studies. Dev Pharmacol Ther, 18(3–4)(161–168, 1992.
  • Treluyer, J., et al., Expression of CYP2D6 in developing human liver. Eur J Biochem, 202(2)(583–588, 1991.
  • Trelyuer, J., et al., Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vivo/in virtro correlation and inducibility. Pharmacogenetics, 7(441–452, 1997.
  • Sonnier, M. and Cresteil, T., Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem, 251(3)(893–898, 1998.
  • Vieira, I., Sonnier, M., and Cresteil, T., Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem, 238(476– 483, 1996.
  • Sipes, I.G., Gandolfi, A.J., Biotrans- formation of toxicants, in Casarett and Doull’s Toxicology, C.D. Klaassen, J.O.A., J. Doull, Ed. Macmillan Pub- lishing Company, New York, 64–98, 1986.
  • Landi, M.T., et al., Chapter 16. Human cytochrome P4501A2. IARC Science Publications, 148(173–195, 1999.
  • Ryan, D.E. and Levin, W., Age- and gender-related expression of rat liver cy- tochrome P450, in Handbook of Experi- mental Pharmacology, J. Schenkman, H.G., Ed. Springer-Verlag, Yew York, 461–476, 1993.
  • Richardson, T.H., Johnson, E.F., The CYP2C subfamily, in Cyto- chromes P450 Metabolic and Toxico- logical Aspects, C, I., Ed. CRC Press, Boca Raton, FL, 161–181, 1996.
  • Vahter, M., Methylation of inorganic arsenic in different mammalian spe- cies and population groups. Science in Progress, 82(Pt 1), 69–88, 1999.
  • Dutton, G.J., Glucuronidation of Drugs and Other Compounds. Boca Raton, FL, CRC Press, 1980.
  • Pastino, G.M., Yap, W.Y., and Carroquino, M., Human variability and susceptibility to trichloroethyl- ene. Environmental Health Perspec- tives, 108(Suppl 2), 201–214, 2000.
  • John, E.G. and Guignard, J.-P., De- velopment of Renal Excretion of Drugs During Ontogeny, in Fetal and Neonatal Physiology, Polin, R. and Fox, W., Eds., W.B. Saunders Com- pany, Philadelphia, 188–193, 1998.
  • Podrazik, P.M. and Schwartz, J.B., Cardiovascular pharmacology of ag- ing. Cardiology Clinics, 17 (1),17– 34, 1999.
  • Stalam, M. and Kaye, D., Antibiotic agents in the elderly. Infectious Dis- ease Clinics of North America, 14(2),357–369, 2000.
  • Bokenkamp, A., et al., Cystatin C— a new marker of glomerular filtration rate in children independent of age and height. Pediatrics, 101 (5),875– 881, 1998.
  • Fletcher, C.V., Acosta, E.P., and Strykowski, J.M., Gender differences in human pharmacokinetics and phar- macodynamics. Journal of Adolescent Health, 15(8),619–629, 1994.
  • Atherton, D.P. and Hunter, J.M., Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clinical Pharmacokinetics, 36(3),169–189, 1999.
  • Tod, M., Padoin, C., and Petitjean, O., Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clinical Pharmacokinetics, 38(3), 205–223, 2000.
  • Sproule, B.A., Hardy, B.G., and Shulman, K.I., Differential pharma- cokinetics of lithium in elderly pa- tients. Drugs and Aging, 16(3),165–177, 2000.
  • Giroux, D., Lapointe, G., and Baril, M., Toxicological index and the pres- ence in the workplace of chemical hazards for workers who breast-feed infants. Am Ind Hyg Assoc J, 53(7),471–474, 1992.
  • Byczkowski, J.Z., Geahart, J.M., and Fisher, J.W., “Occupational” exposure of infants to toxic chemicals via breast milk. Nutrition, 10(1),43–48, 1994.
  • Shelley, M.L., Andersen, M.E., and Fisher, J.W., A risk assessment ap- proach for nursing infants exposed to volatile organics through the mother’s occupational inhalation exposure. Appl Ind Hyg, 4(1),21–26, 1989.
  • Byczkowski, J.Z. and Fisher, J.W., Tetrachloroethylene exposure assess- ment of breast-fed infants. undated.
  • Byczkowski, J., Lactional Transfer of Chemicals. Seminar presentation. February 5, 1992. 1992.
  • Miller, R.K., Koszalka, T.R., and Brent, R.L., The transport of mol- ecules across placental membranes, in The Cell Surface in animal Em- bryogenesis and Development, Poste, G. and Nicolson, G.L., Eds., Elsevier, New York, 145–223, 1976.
  • Guyton, A.C. and Hall, J.E., Text- book of Medical Physiology. 9th ed. Philadelphia, W.B. Saunders Com- pany, 1996.
  • Widdowson, E.M., Changes in Body Proportions and Compositions Dur- ing Growth, in Scientific Founda- tions of Paediatrics, Davis, J. and Dobbing, J., Eds., W. Heinemann Medical Books Ltd;, London, 153– 163, 1974.
  • Pikkarainen, P.H. and Raiha, N.C., Development of alcohol dehydroge- nase activity in the human liver. Pe- diatric Research, 1(3),165–168, 1967.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.